4Verbeek WH, Van De Water JM, et al. Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-basedregistry in The Netherlands [j]. Scand J Gastroenterol, 2008, 43(11):1322-1328. 被引量：1
5Swerdlow SH, Campo E, Harris N, et al. WHO Classification ofTumours of Haematopoietic and Lymphoid Tissues[C]. Lyon: IARCPress; 2008: 289-291. 被引量：1
6Rohatiner A, d Am ore F, Coiffier B, et al. Report on a workshopconvened to discuss the pathological and staging classifications ofgastrointestinal tract lymphoma [J]. Ann Oncol, 1994,5(5): 397-400. 被引量：1
7Di Sabatino A, Biagi F; Gobbi PG, et al. How I treat enteropathy-associated T-cell lymphoma[j]. Blood; 2012,119( 11): 2458-2468. 被引量：1
8Gallamini A, Stelitano C; Calvi R, et al. Peripheral T-cell lymphomaunspecified(PTCL-U): a new prognostic model from a retrospectivemulticentric clinical study[j]. Blood, 2004,103(7): 2474-2479. 被引量：1
9Wilson WH, Grossbard ML, Pittaluga S, et al. Dose-adjustedEPOCH chemotherapy for untreated large B-cell lymphomas: apharmacodynamic approach with high efficacy[j]. Blood, 2002, 99(8):2685-2693. 被引量：1
10Cheson BD, Pfistner B, Juweid ME, et al. International HarmonizationProject on Lymphoma. Revised response criteria for malignantlymphoma[j].J Clin Oncol, 2007, 25(5): 579-586. 被引量：1
